CN102657839A - Traditional Chinese medicine capsule for treating coronary heart disease - Google Patents
Traditional Chinese medicine capsule for treating coronary heart disease Download PDFInfo
- Publication number
- CN102657839A CN102657839A CN2012101774034A CN201210177403A CN102657839A CN 102657839 A CN102657839 A CN 102657839A CN 2012101774034 A CN2012101774034 A CN 2012101774034A CN 201210177403 A CN201210177403 A CN 201210177403A CN 102657839 A CN102657839 A CN 102657839A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- semen
- rhizoma
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention provides a traditional Chinese medicine capsule for treating coronary heart disease. The capsule is prepared by the following raw materials of traditional Chinese medicine: spina date seed, peach seed, flos carthami, coptidis rhizoma, red peony root, fructus aurantii, platycodon grandiflorum, sanders, radix cyathulae, longstamen onion bulb, olibanum, myrrh, trogopterus dung, fructus aurantii immaturus, cassia twig, rhizoma chuanxiong, fructus lycii, bamboo shavings, dried ginger, radix scutellariae, prepared rehmannia root, poria cocos, angelica sinensis, polyporus umbellatus, plantain seed, platycladi seed and eucommia. The capsule which is prepared by utilizing traditional Chinese herbal medicine as raw materials and scientifically composing and repeatedly verified by clinical experiments accords with theories of traditional Chinese medicine, has functions of activating blood and dissolving stasis, easing joint movement and opening orifices, tonifying Qi and recuperating depleted Yang and the like and can improve coronary blood flow and enhance myocardial oxygen content to enable myocardium to need more blood so as to achieve activity of opening coronary artery blood wall to improve the elasticity of the coronary artery. The traditional Chinese medicine capsule for treating the coronary heart disease has the advantages that the capsule is free of toxicity and side effects, high in radical treatment efficiency, low in treatment cost and short in treatment course.
Description
1, technical field
The present invention relates to a kind of Chinese medicine preparation, specifically a kind of Chinese medicinal capsule of treating coronary heart disease.
2, background technology
Coronary heart disease is a kind of myocardial ischemia-anoxemia (angina pectoris) that is caused by coronary artery organic (atherosclerosis or dynamic property vasospasm) stenosis or occlusion or the heart disease of myocardial necrosis (myocardial infarction).Our the coronary heart disease majority said is that tremulous pulse organic stenosis or obstruction cause at ordinary times, and the shape atherosclerotic heart disease wins again.Due to its coronary stricture polyphyly fatty material was piled up along blood vessel, this process was called arteriosclerosis.Arteriosclerosis develops into to a certain degree, and coronary stricture increases the weight of gradually, and restriction flows into the blood flow of cardiac muscle.Heart can not get enough oxygen and supplies with, and the chest discomfort will take place, i.e. angina pectoris.The cause of coronary heart disease reason is many-sided, and changing with whole machine body has confidential relation.Main aspect is that healthy energy is lost empty because worn with age, function damage, yin and yang qi and blood disorder, the influence of factors such as work and rest mistake degree.Aspect treatment, need adopt benefiting vital QI and blood, nourishing YIN and invigorating YANG and so on treatment by Chinese herbs.
3, summary of the invention
The purpose of this invention is to provide a kind of Chinese medicinal capsule of treating coronary heart disease, can reach treating both the principal and secondary aspects of a disease, eliminate clinical manifestation rapidly, finally reach the healing purpose for this preparation of coronary heart disease.
Technical problem to be solved by this invention provide a kind of simpler than prior art processing technology, curative effect is quick, cure rate is high, be difficult for a kind of Chinese medicinal capsule of treating coronary heart disease of recurrence.It is raw material that medicine of the present invention is to use Chinese traditional Chinese herbal medicine, passes through the prescription of science, and formulated through the repeated validation of clinical trial, meets the theory of Chinese medicine.
A kind of Chinese medicinal capsule of treating coronary heart disease of the present invention is to be processed by the crude drug of following weight ratio:
Semen Ziziphi Spinosae 3-8 part, Semen Persicae 2-5 part, Flos Carthami 2-7 part, Rhizoma Coptidis 1-5 part,
Radix Paeoniae Rubra 3-8 part, Fructus Aurantii 5-12 part, Radix Platycodonis 2-12 part, Lignum Santali Albi 3-7 part,
Radix Cyathulae 2-5 part, Bulbus Allii Macrostemonis 2-8 part, Olibanum 5-12 part, Myrrha 3-8 part,
Oletum Trogopterori 3-8 part, Fructus Aurantii Immaturus 5-10 part, Ramulus Cinnamomi 3-8 part, Rhizoma Chuanxiong 5-12 part,
Fructus Lycii 2-5 part, Caulis Bambusae In Taenia 1-5 part, Rhizoma Zingiberis 1-3 part, Radix Scutellariae 3-8 part,
Radix Rehmanniae Preparata 5-10 part, Poria 3-10 part, Radix Angelicae Sinensis 2-5 part, Polyporus 2-5 part,
Semen Plantaginis 3-8 part, Semen Platycladi 5-12 part, Cortex Eucommiae 2-5 part;
Preparation process is following:
(1), by formula proportion with Semen Ziziphi Spinosae, Semen Persicae, Flos Carthami, Rhizoma Coptidis, Radix Paeoniae Rubra, Fructus Aurantii, Radix Platycodonis, that Lignum Santali Albi is ground into fine powder is subsequent use;
(2), will remain Chinese herbal medicine according to formula proportion and clean, screening is put into marmite and was boiled 15-20 minute in 150-180 ℃, extracts supernatant and is cooled to room temperature, filtrate for later use; Slag is added water again, decoct and after boiling, pour filtrating into,, be cooled to room temperature after bake dry grinding to 300-400 order fine powder until being boiled into the thick paste shape;
(3), incapsulate behind method for preparing (1) and (2) fine powder mix homogeneously and place the disinfecting container of high temperature >=100 ℃ to carry out disinfection, get product.
A kind of Chinese medicinal capsule of treating coronary heart disease of the present invention is to be processed by the crude drug of following weight ratio:
Semen Ziziphi Spinosae 5-7 part, Semen Persicae 3-4 part, Flos Carthami 3-5 part, Rhizoma Coptidis 2-4 part,
Radix Paeoniae Rubra 4-6 part, Fructus Aurantii 8-10 part, Radix Platycodonis 5-10 part, Lignum Santali Albi 3-5 part,
Radix Cyathulae 3-4 part, Bulbus Allii Macrostemonis 4-6 part, Olibanum 6-10 part, Myrrha 5-6 part,
Oletum Trogopterori 4-6 part, Fructus Aurantii Immaturus 6-8 part, Ramulus Cinnamomi 5-6 part, Rhizoma Chuanxiong 6-10 part,
Fructus Lycii 3-4 part, Caulis Bambusae In Taenia 3-4 part, Rhizoma Zingiberis 1-2 part, Radix Scutellariae 4-6 part,
Radix Rehmanniae Preparata 6-8 part, Poria 5-8 part, Radix Angelicae Sinensis 3-4 part, Polyporus 3-4 part,
Semen Plantaginis 5-6 part, Semen Platycladi 6-10 part, Cortex Eucommiae 3-4 part.
A kind of Chinese medicinal capsule of treating coronary heart disease of the present invention is to be processed by the crude drug of following weight ratio:
6 parts of Semen Ziziphi Spinosaes, 3 parts in Semen Persicae, 4 parts on Flos Carthami, 3 parts of Rhizoma Coptidis,
5 parts of Radix Paeoniae Rubras, 8 parts of Fructus Aurantiis, 7 parts of Radix Platycodoniss, 4 parts in Lignum Santali Albi,
3 parts of Radix Cyathulaes, 5 parts of Bulbus Allii Macrostemonis, 8 parts of Olibanums, 5 parts of Myrrhas,
5 parts of Oletum Trogopteroris, 7 parts of Fructus Aurantii Immaturuss, 6 parts of Ramulus Cinnamomi, 8 parts of Rhizoma Chuanxiongs,
4 parts of Fructus Lycii, 3 parts of Caulis Bambusae In Taenia, 2 parts of Rhizoma Zingiberiss, 5 parts of Radix Scutellariaes,
7 parts of Radix Rehmanniae Preparata, 6 parts in Poria, 3.5 parts of Radix Angelicae Sinensis, 4 parts of Polyporus,
6 parts of Semen Plantaginiss, 8 parts of Semen Platycladi, 4 parts of the Cortexs Eucommiae.
Chinese medicinal capsule of the present invention has activating blood circulation to dissipate blood stasis, is open to the custom and has one's ideas straightened out, effects such as invigorating vital QI and recuperating the depleted YANG.Can improve CF, strengthen myocardium oxygen content, make the increase in demand of cardiac muscle, reach the activity of mediation coronary blood tube wall, coronary artery elasticity is increased blood.The outstanding good effect of this Chinese medicinal capsule is a no side effects, and radical cure efficient is high, and medical expense is low, short treating period.
4, the specific embodiment
Embodiment 1
Semen Ziziphi Spinosae 3g, Semen Persicae 2g, Flos Carthami 2g, Rhizoma Coptidis 1g,
Radix Paeoniae Rubra 3g, Fructus Aurantii 5g, Radix Platycodonis 2g, Lignum Santali Albi 3g,
Radix Cyathulae 2g, Bulbus Allii Macrostemonis 2g, Olibanum 5g, Myrrha 3g,
Oletum Trogopterori 3g, Fructus Aurantii Immaturus 5g, Ramulus Cinnamomi 3g, Rhizoma Chuanxiong 5g,
Fructus Lycii 2g, Caulis Bambusae In Taenia 1g, Rhizoma Zingiberis 1g, Radix Scutellariae 3g,
Radix Rehmanniae Preparata 5g, Poria 3g, Radix Angelicae Sinensis 2g, Polyporus 2g,
Semen Plantaginis 3g, Semen Platycladi 5g, Cortex Eucommiae 2g.
Preparation process is following:
(1), by formula proportion with Semen Ziziphi Spinosae, Semen Persicae, Flos Carthami, Rhizoma Coptidis, Radix Paeoniae Rubra, Fructus Aurantii, Radix Platycodonis, that Lignum Santali Albi is ground into fine powder is subsequent use;
(2), will remain Chinese herbal medicine according to formula proportion and clean, screening is put into marmite and was boiled 15 minutes in 150 ℃, extracts supernatant and is cooled to room temperature, filtrate for later use; Slag is added water again, decoct and after boiling, pour filtrating into,, be cooled to room temperature after bake dry grinding to 300 order fine powder until being boiled into the thick paste shape;
(3), incapsulate behind method for preparing (1) and (2) fine powder mix homogeneously and place the disinfecting container of high temperature >=100 ℃ to carry out disinfection, get product.
Embodiment 2
Semen Ziziphi Spinosae 8g, Semen Persicae 5g, Flos Carthami 7g, Rhizoma Coptidis 5g,
Radix Paeoniae Rubra 8g, Fructus Aurantii 12g, Radix Platycodonis 12g, Lignum Santali Albi 7g,
Radix Cyathulae 5g, Bulbus Allii Macrostemonis 8g, Olibanum 12g, Myrrha 8g,
Oletum Trogopterori 8g, Fructus Aurantii Immaturus 10g, Ramulus Cinnamomi 8g, Rhizoma Chuanxiong 12g,
Fructus Lycii 5g, Caulis Bambusae In Taenia 5g, Rhizoma Zingiberis 3g, Radix Scutellariae 8g,
Radix Rehmanniae Preparata 10g, Poria 10g, Radix Angelicae Sinensis 5g, Polyporus 5g,
Semen Plantaginis 8g, Semen Platycladi 12g, Cortex Eucommiae 5g.
Preparation process is following:
(1), by formula proportion with Semen Ziziphi Spinosae, Semen Persicae, Flos Carthami, Rhizoma Coptidis, Radix Paeoniae Rubra, Fructus Aurantii, Radix Platycodonis, that Lignum Santali Albi is ground into fine powder is subsequent use;
(2), will remain Chinese herbal medicine according to formula proportion and clean, screening is put into marmite and was boiled 20 minutes in 180 ℃, extracts supernatant and is cooled to room temperature, filtrate for later use; Slag is added water again, decoct and after boiling, pour filtrating into,, be cooled to room temperature after bake dry grinding to 400 order fine powder until being boiled into the thick paste shape;
(3), incapsulate behind method for preparing (1) and (2) fine powder mix homogeneously and place the disinfecting container of high temperature >=100 ℃ to carry out disinfection, get product.
Embodiment 3
Semen Ziziphi Spinosae 5g, Semen Persicae 3g, Flos Carthami 3g, Rhizoma Coptidis 2g,
Radix Paeoniae Rubra 4g, Fructus Aurantii 8g, Radix Platycodonis 5g, Lignum Santali Albi 3g,
Radix Cyathulae 3g, Bulbus Allii Macrostemonis 4g, Olibanum 6g, Myrrha 5g,
Oletum Trogopterori 4g, Fructus Aurantii Immaturus 6g, Ramulus Cinnamomi 5g, Rhizoma Chuanxiong 6g,
Fructus Lycii 3g, Caulis Bambusae In Taenia 3g, Rhizoma Zingiberis 1g, Radix Scutellariae 4g,
Radix Rehmanniae Preparata 6g, Poria 5g, Radix Angelicae Sinensis 3g, Polyporus 3g,
Semen Plantaginis 5g, Semen Platycladi 6g, Cortex Eucommiae 3g.
Preparation process is identical with embodiment 2.
Embodiment 4
Semen Ziziphi Spinosae 7g, Semen Persicae 4g, Flos Carthami 5g, Rhizoma Coptidis 4g,
Radix Paeoniae Rubra 6g, Fructus Aurantii 10g, Radix Platycodonis 10g, Lignum Santali Albi 5g,
Radix Cyathulae 4g, Bulbus Allii Macrostemonis 6g, Olibanum 10g, Myrrha 6g,
Oletum Trogopterori 6g, Fructus Aurantii Immaturus 8g, Ramulus Cinnamomi 6g, Rhizoma Chuanxiong 10g,
Fructus Lycii 4g, Caulis Bambusae In Taenia 4g, Rhizoma Zingiberis 2g, Radix Scutellariae 6g,
Radix Rehmanniae Preparata 8g, Poria 8g, Radix Angelicae Sinensis 4g, Polyporus 4g,
Semen Plantaginis 6g, Semen Platycladi 10g, Cortex Eucommiae 4g.
Preparation process is identical with embodiment 1.
Embodiment 5
Semen Ziziphi Spinosae 6g, Semen Persicae 3g, Flos Carthami 4g, Rhizoma Coptidis 3g,
Radix Paeoniae Rubra 5g, Fructus Aurantii 8g, Radix Platycodonis 7g, Lignum Santali Albi 4g,
Radix Cyathulae 3g, Bulbus Allii Macrostemonis 5g, Olibanum 8g, Myrrha 5g,
Oletum Trogopterori 5g, Fructus Aurantii Immaturus 7g, Ramulus Cinnamomi 6g, Rhizoma Chuanxiong 8g,
Fructus Lycii 4g, Caulis Bambusae In Taenia 3g, Rhizoma Zingiberis 2g, Radix Scutellariae 5g,
Radix Rehmanniae Preparata 7g, Poria 6g, Radix Angelicae Sinensis 3.5g, Polyporus 4g,
Semen Plantaginis 6g, Semen Platycladi 8g, Cortex Eucommiae 4g.
Preparation process is following:
(1), by formula proportion with Semen Ziziphi Spinosae, Semen Persicae, Flos Carthami, Rhizoma Coptidis, Radix Paeoniae Rubra, Fructus Aurantii, Radix Platycodonis, that Lignum Santali Albi is ground into fine powder is subsequent use;
(2), will remain Chinese herbal medicine according to formula proportion and clean, screening is put into marmite and was boiled 15 minutes in 180 ℃, extracts supernatant and is cooled to room temperature, filtrate for later use; Slag is added water again, decoct and after boiling, pour filtrating into,, be cooled to room temperature after bake dry grinding to 400 order fine powder until being boiled into the thick paste shape;
(3), incapsulate behind method for preparing (1) and (2) fine powder mix homogeneously and place the disinfecting container of high temperature >=100 ℃ to carry out disinfection, get product.
MethodsThe cases enrolled: in the 100 routine patients that cure with this prescription, wherein male 57 examples, women 43 examples, the course of disease is the shortest 3 months, and is the longest 15 years.
Efficacy determination: adopt 4 grade standards
Recovery from illness clinical improvements rate >=95%;
Produce effects clinical improvements rate＜95%, >=60%;
Effective clinical improvements rate＜60%, >=20%;
Invalid clinical improvements rate＜20%;
Therapeutic outcome is seen table
Its treatment cure rate of Chinese medicinal capsule that the present invention treats coronary heart disease is 82%, and effectively cure rate is 95%.
Model case
1, Chen, the man, 52 years old, cardinal symptom be the vexed pain in anterior pectorial region unbearably, and show effect 2-3 time every day, be coronary heart disease through hospital diagnosis, the wheat harvesting period of being in hospital oneself is left hospital economic unable support through the invalid back of conventional western medical treatment.Take Chinese medicinal capsule twice, 2 week of every day back symptom of the present invention and alleviate to some extent, transference cure after 4 weeks, not recurrence is followed up a case by regular visits to so far in the back recovery from illness of 1 week of after treatment again.
2, Lee so-and-so, the woman, 59 years old, showed effect 4-6 every day, each a few minutes, the patient is painful especially, is diagnosed as coronary heart disease, and is repeatedly invalid behind the hospitalization.Take Chinese medicinal capsule of the present invention upon somebody's introduction.Sooner or later respectively take medicine 2 times every day, only shows effect 1-2 time every day in the 1 all backs of taking medicine, symptom basic controlling after 3 weeks of taking medicine, and state of an illness recovery from illness after 5 weeks in 2 weeks of after treatment, is followed up a case by regular visits to so far recurrence.
3, Zhang, the man, 77 years old, inspection in 38 years old was to have found coronary heart disease, though obey multiple medicine, the state of an illness is often outbreak still, patient's sick time reaches 40 years.Take Chinese medicinal capsule of the present invention every day twice, take medicine 3 week the back symptoms alleviate to some extent, continue to take medicine 3 week the back transference cures.Recurrence to some extent after 2 years, the back recovery from illness of 2 weeks continues again to take medicine.
4, Chen, the woman, 50 years old, suffer from coronary heart disease, myocardial ischemia 4 years, need be in hospital 2-3 month every year in hospital.Introduce through friend and to begin to take Chinese medicinal capsule of the present invention, take medicine every day 2 times, after 2 weeks of taking medicine, breathe hard, symptom uncomfortable in chest alleviates to some extent, the 3 weeks back recovery from illness that continues again to take medicine is followed up a case by regular visits to nothing repeatedly.
5, ten thousand certain, woman 73 years old suffers from coronary heart disease, causes symptoms such as nervous, uncomfortable in chest, arrhythmia, two shank swelling.Take pure Chinese medicine capsule of the present invention every day 2 times, 4 week the back above-mentioned symptoms disappear basically, the back recovery from illness of 3 weeks continues again to take medicine.
6, Zhao so-and-so, the man, 60 years old, found to suffer from coronary heart disease before 10 years, the Drug therapy of always not breaking so far comes in often to take place symptom dizzy, vomiting.Take pure Chinese medicine capsule of the present invention every day 2 times, take medicine two week the back symptoms alleviate to some extent, continuations need 2 week the back fully recover.
Claims (3)
1. Chinese medicinal capsule of treating coronary heart disease is characterized in that being processed by following materials of weight proportions medicine:
Semen Ziziphi Spinosae 3-8 part, Semen Persicae 2-5 part, Flos Carthami 2-7 part, Rhizoma Coptidis 1-5 part,
Radix Paeoniae Rubra 3-8 part, Fructus Aurantii 5-12 part, Radix Platycodonis 2-12 part, Lignum Santali Albi 3-7 part,
Radix Cyathulae 2-5 part, Bulbus Allii Macrostemonis 2-8 part, Olibanum 5-12 part, Myrrha 3-8 part,
Oletum Trogopterori 3-8 part, Fructus Aurantii Immaturus 5-10 part, Ramulus Cinnamomi 3-8 part, Rhizoma Chuanxiong 5-12 part,
Fructus Lycii 2-5 part, Caulis Bambusae In Taenia 1-5 part, Rhizoma Zingiberis 1-3 part, Radix Scutellariae 3-8 part,
Radix Rehmanniae Preparata 5-10 part, Poria 3-10 part, Radix Angelicae Sinensis 2-5 part, Polyporus 2-5 part,
Semen Plantaginis 3-8 part, Semen Platycladi 5-12 part, Cortex Eucommiae 2-5 part;
Preparation process is following:
(1), by formula proportion with Semen Ziziphi Spinosae, Semen Persicae, Flos Carthami, Rhizoma Coptidis, Radix Paeoniae Rubra, Fructus Aurantii, Radix Platycodonis, that Lignum Santali Albi is ground into fine powder is subsequent use;
(2), will remain Chinese herbal medicine according to formula proportion and clean, screening is put into marmite and was boiled 15-20 minute in 150-180 ℃, extracts supernatant and is cooled to room temperature, filtrate for later use; Slag is added water again, decoct and after boiling, pour filtrating into,, be cooled to room temperature after bake dry grinding to 300-400 order fine powder until being boiled into the thick paste shape;
(3), incapsulate behind method for preparing (1) and (2) fine powder mix homogeneously and place the disinfecting container of high temperature >=100 ℃ to carry out disinfection, get product.
2. a kind of Chinese medicinal capsule of treating coronary heart disease according to claim 1 is characterized in that being processed by following materials of weight proportions medicine:
Semen Ziziphi Spinosae 5-7 part, Semen Persicae 3-4 part, Flos Carthami 3-5 part, Rhizoma Coptidis 2-4 part,
Radix Paeoniae Rubra 4-6 part, Fructus Aurantii 8-10 part, Radix Platycodonis 5-10 part, Lignum Santali Albi 3-5 part,
Radix Cyathulae 3-4 part, Bulbus Allii Macrostemonis 4-6 part, Olibanum 6-10 part, Myrrha 5-6 part,
Oletum Trogopterori 4-6 part, Fructus Aurantii Immaturus 6-8 part, Ramulus Cinnamomi 5-6 part, Rhizoma Chuanxiong 6-10 part,
Fructus Lycii 3-4 part, Caulis Bambusae In Taenia 3-4 part, Rhizoma Zingiberis 1-2 part, Radix Scutellariae 4-6 part,
Radix Rehmanniae Preparata 6-8 part, Poria 5-8 part, Radix Angelicae Sinensis 3-4 part, Polyporus 3-4 part,
Semen Plantaginis 5-6 part, Semen Platycladi 6-10 part, Cortex Eucommiae 3-4 part.
3. a kind of Chinese medicinal capsule of treating coronary heart disease according to claim 1 is characterized in that being processed by following materials of weight proportions medicine:
6 parts of Semen Ziziphi Spinosaes, 3 parts in Semen Persicae, 4 parts on Flos Carthami, 3 parts of Rhizoma Coptidis,
5 parts of Radix Paeoniae Rubras, 8 parts of Fructus Aurantiis, 7 parts of Radix Platycodoniss, 4 parts in Lignum Santali Albi,
3 parts of Radix Cyathulaes, 5 parts of Bulbus Allii Macrostemonis, 8 parts of Olibanums, 5 parts of Myrrhas,
5 parts of Oletum Trogopteroris, 7 parts of Fructus Aurantii Immaturuss, 6 parts of Ramulus Cinnamomi, 8 parts of Rhizoma Chuanxiongs,
4 parts of Fructus Lycii, 3 parts of Caulis Bambusae In Taenia, 2 parts of Rhizoma Zingiberiss, 5 parts of Radix Scutellariaes,
7 parts of Radix Rehmanniae Preparata, 6 parts in Poria, 3.5 parts of Radix Angelicae Sinensis, 4 parts of Polyporus,
6 parts of Semen Plantaginiss, 8 parts of Semen Platycladi, 4 parts of the Cortexs Eucommiae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101774034A CN102657839B (en) | 2012-06-01 | 2012-06-01 | Traditional Chinese medicine capsule for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101774034A CN102657839B (en) | 2012-06-01 | 2012-06-01 | Traditional Chinese medicine capsule for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102657839A true CN102657839A (en) | 2012-09-12 |
| CN102657839B CN102657839B (en) | 2013-08-28 |
Family
ID=46767506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101774034A Active CN102657839B (en) | 2012-06-01 | 2012-06-01 | Traditional Chinese medicine capsule for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102657839B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103877343A (en) * | 2014-04-09 | 2014-06-25 | 孙树芹 | Traditional Chinese medicinal composition for treating coronary heart disease |
| CN104225531A (en) * | 2014-09-12 | 2014-12-24 | 王园园 | Traditional Chinese medicine for treating coronary heart disease |
| CN105853747A (en) * | 2016-06-07 | 2016-08-17 | 全运明 | Traditional Chinese medicine composition for treating coronary heart disease |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN101380444A (en) * | 2004-12-27 | 2009-03-11 | 杨俭 | Formulation for treating apoplexy |
| CN101380455A (en) * | 2004-12-27 | 2009-03-11 | 杨俭 | Formulation for treating apoplexy |
| WO2010034134A1 (en) * | 2008-09-25 | 2010-04-01 | Weng Xiaotao | Preparation method of concentrated pill of chinese medicine |
| WO2010053456A1 (en) * | 2008-11-10 | 2010-05-14 | Moleac Pte. Ltd. | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
-
2012
- 2012-06-01 CN CN2012101774034A patent/CN102657839B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN101380444A (en) * | 2004-12-27 | 2009-03-11 | 杨俭 | Formulation for treating apoplexy |
| CN101380455A (en) * | 2004-12-27 | 2009-03-11 | 杨俭 | Formulation for treating apoplexy |
| WO2010034134A1 (en) * | 2008-09-25 | 2010-04-01 | Weng Xiaotao | Preparation method of concentrated pill of chinese medicine |
| WO2010053456A1 (en) * | 2008-11-10 | 2010-05-14 | Moleac Pte. Ltd. | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103877343A (en) * | 2014-04-09 | 2014-06-25 | 孙树芹 | Traditional Chinese medicinal composition for treating coronary heart disease |
| CN104225531A (en) * | 2014-09-12 | 2014-12-24 | 王园园 | Traditional Chinese medicine for treating coronary heart disease |
| CN105853747A (en) * | 2016-06-07 | 2016-08-17 | 全运明 | Traditional Chinese medicine composition for treating coronary heart disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102657839B (en) | 2013-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105055606A (en) | Medicine for treating influenza | |
| CN101229267A (en) | Medicine compounds for pulmonary and rheumatic heart disease and preparing method thereof | |
| CN102657839B (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN101658657B (en) | Drug for treating chronic cholecystitis | |
| CN102430071A (en) | Medicament for treating herpes zoster | |
| CN104784511A (en) | Medicine for treating coronary heart disease | |
| CN103041271B (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN103007214B (en) | Chinese medicinal composition for treating palpitation | |
| CN1097621A (en) | Anti-cancer powder | |
| CN104173727A (en) | Medicine for treating toothache | |
| CN102038930A (en) | Medicament for treating protrusion of lumbar vertebral disc | |
| CN102370688A (en) | Compound Chinese medicinal preparation for treating hyperosteogeny and preparation method thereof | |
| CN102846928A (en) | A Chinese medicinal formulation for treating coronary heart disease | |
| CN105920296A (en) | Traditional Chinese medicine preparation for adjuvant treatment of angina pectoris in qi-and-yin-deficiency type coronary heart diseases, and preparation method thereof | |
| CN101032573B (en) | Medicine for treating psoriasis and its preparing process | |
| CN104873911A (en) | Traditional Chinese medicine for oral administration for adjunctively treating sepsis | |
| CN101239140A (en) | Chinese medicine for treating psoriasis | |
| CN104013945A (en) | Traditional Chinese medicine (TCM) preparation for treating coronary heart diseases | |
| CN102846911A (en) | Drug for treating coronary heart disease | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN102274358B (en) | Traditional Chinese medicine for treating premature menstruation, profuse menstruation, breast distending pain and large clot quantity | |
| CN104288338A (en) | Traditional Chinese medicine for treating ankylosing spondylitis | |
| CN102114183A (en) | Medicament for treating hypertension | |
| CN103816433B (en) | A kind of Chinese medicine for the treatment of astriction of qi deficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SUN QINGCAI Free format text: FORMER OWNER: ZHU XINHUA Effective date: 20130718 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Sun Qingcai Inventor before: Zhu Xinhua |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHU XINHUA TO: SUN QINGCAI Free format text: CORRECT: ADDRESS; FROM: 250031 JINAN, SHANDONG PROVINCE TO: 273200 JINING, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130718 Address after: 273200 Surabaya Hospital of traditional Chinese medicine, Jining, Shandong Applicant after: Sun Qingcai Address before: 250031 General Hospital of Jinan Military Area, 25 normal road, Shandong, Ji'nan Applicant before: Zhu Xinhua |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HAIMEN FENGCHENG TOURIST ATTRACTIONS DEVELOPMENT C Free format text: FORMER OWNER: SUN QINGCAI Effective date: 20140422 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 273200 JINING, SHANDONG PROVINCE TO: 226152 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140422 Address after: Yu Dong Wenfeng road 226152 Jiangsu Haimen city of Nantong Province Patentee after: Haimen Fengcheng tourist attractions development Co., Ltd. Address before: 273200 Surabaya Hospital of traditional Chinese medicine, Jining, Shandong Patentee before: Sun Qingcai |